0021 GMT - ImpediMed's shares are up 27% so far this month as investors warm to the growth outlook for its Sozo bioimpedance spectroscopy-based device, which allows monitoring of heart-failure patients at home. Morgans points to technical charts showing the relative strength index indicator has entered bull-market range, increasing its confidence that the stock is at a turning point. "A break above resistance of A$0.85 is highly likely with initial upside price target of A$1.00," Morgans says. A mild pull back could happen in the short term and if it does then A$0.70 would provide a good buying opportunity, the broker adds. ImpediMed is at A$0.79 early in Asia on Friday.
(END) Dow Jones Newswires
September 21, 2017 20:21 ET (00:21 GMT)
0021 GMT - ImpediMed's shares are up 27% so far this month as...
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
-0.002(3.39%) |
Mkt cap ! $115.3M | |||
| Open | High | Low | Value | Volume |
| 5.8¢ | 5.9¢ | 5.6¢ | $103.9K | 1.809M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 886266 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 329600 | 2 |
View Market Depth
| Last trade - 15.59pm 08/08/2024 (20 minute delay) ? |
| IPD (ASX) Chart |